Pinealon

Also known as: EDR peptide

CognitivePRECLINICAL

Clinical Status

Preclinical — primarily Russian research.

Mechanism of Action

A tripeptide (Glu-Asp-Arg) that targets pineal gland and central nervous system tissue. Modulates melatonin synthesis, promotes neuroprotection, and may regulate circadian rhythm-related gene expression.

Dosing Defaults

Dose

10 mg

Frequency

1x daily

Administration

Oral capsule or sublingual

Timing

Evening

Food

fasted

Duration

10-20 day cycles

Dose range: 5-20 mg daily

Evening dosing supports melatonin regulation and sleep architecture.

Side Effects

•Drowsiness
•Headache
•Vivid dreams

Contraindications & Warnings

•Not medical advice
•Limited Western clinical data

Compare

Compare Pinealon with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Pinealon dose.

Open Calculator

Related Cognitive Peptides

Selank

PHASE 2

Cognitive

Anxiolytic peptide approved in Russia. Non-sedative, non-addictive.

Semax

PHASE 2

Cognitive

Nootropic peptide approved in Russia. Enhances focus, memory, and neuroplasticity.

Dihexa

PRECLINICAL

Cognitive

Potent nootropic that promotes synapse formation. No human trials.

Noopept

PHASE 2

Cognitive

Dipeptide-derived nootropic for memory and neuroprotection. Approved in Russia.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.